BackgroundBudesonide foam is effective in inducing clinical remission in ulcerative colitis (UC) patients with active proctosigmoiditis. The aim of this study was to evaluate the duration of remission and predictors of relapse in UC patients who achieved clinical remission and mucosal healing by 6-week treatment with topical budesonide. MethodsThis is a retrospective. observational. https://parisnaturalfoodes.shop/product-category/clarifying-shampoo/